Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Rarely, GLP-1 receptor agonists have been associated with pancreatitis (inflammation of the pancreas)
The drug acts similarly to the bodys own GLP-1 hormone, which is released after eating and triggers insulin release
Over 72 weeks, participants without type 2 diabetes achieved the following weight loss results : 5 mg dose: 16.0% average body weight reduction 10 mg dose: 21.4% average body weight reduction 15 mg dose: 22.5% average body weight reduction Placebo: 2.4% average body weight reduction At the highest dose, 92.7% of participants achieved at least 5% weight loss, 84.4% achieved at least 10%, 73.6% achieved at least 15%, 56.1% achieved at least 20%, and 38.7% achieved at least 25% weight loss
(2024) 15:e20230003
Precision medicine approaches currently experimental but likely becoming standard within coming decades
US$ 22.79
US$ 24.17
US$ 24.48
US$ 21.99
US$ 29.09
US$ 21.92
US$ 20.81
US$ 21.64
US$ 28.34
